EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rising challenges in periprosthetic joint infections: a focus on rare pathogens and their clinical implications

Jianhua Lyu, Jiagu Huang, Jiexin Huang, Hongxin Hu, Qijin Wang, Haiqi Ding, Hongyan Li, Xinyu Fang, Wenming Zhang

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1451398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Jianhua Lyu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Knee, Anti-Bacterial Agents, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The study aimed to evaluate differences in clinical characteristics and treatment outcomes of periprosthetic joint infection (PJI) attributed to rare versus common pathogens.

Methods

Data on PJI patients who underwent hip or knee arthroplasty at our center from April 2013 to December 2022 were retrospectively collected. Among the 219 enrolled patients, we compared 32 cases of PJI caused by rare pathogens with 187 controls of PJI caused by common pathogens, analyzing demographic information, clinical characteristics, and treatment outcomes.

Results

In demographic data, the Charlson comorbidity index and preoperative invasive procedures were identified as risk factors for rare pathogen PJI. Clinically, the rare pathogen cohort exhibited a significantly higher rate of sinus tract formation compared to those with common bacteria PJI. In terms of laboratory findings, the mean serum C-reactive protein (CRP) was significantly lower in the rare pathogen group. This cohort also had a significantly lower culture positivity rate and a higher rate of polymicrobial co-infections. The median hospital stay was statistically longer for rare pathogen PJI cases than for those with common bacteria PJI. Furthermore, the rare pathogen group required longer antibiotic treatments and had higher rates of antibiotic-related adverse events, although reinfection rates did not significantly differ.

Conclusion

PJI caused by rare pathogens exhibits distinct clinical presentations. With advances in diagnostic techniques such as metagenomic next-generation sequencing (mNGS), optimized culture methods, and an interdisciplinary approach facilitating early targeted treatment, rare pathogen PJIs may achieve outcomes comparable to those of typical cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, KneeAnti-Bacterial AgentsArthroplasty, Replacement, HipHumansMaleFemaleAgedRetrospective StudiesMiddle AgedRisk FactorsTreatment OutcomeBacteriaAged, 80 and overCoinfectionC-Reactive Protein

Stichwörter der Autor:innen

microbiologynext-generation sequencingperiprosthetic joint infectionrare pathogenrevision

Substanzen

Anti-Bacterial AgentsC-Reactive Protein

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Orthopaedic Surgery, Affiliated Hospital of Putian University, Putian, China.
  • Department of Orthopaedic Surgery, National Regional Medical Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Fujian Provincial Institute of Orthopaedics, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Orthopaedic Surgery, Ningde Municipal Hospital of Ningde Normal University, Ningde, China.
  • Department of Orthopaedic Surgery, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China.

Zitieren

APA

Lyu, J., Huang, J., Huang, J., Hu, H., Wang, Q., Ding, H., Li, H., Fang, X., & Zhang, W. (2024). Rising challenges in periprosthetic joint infections: a focus on rare pathogens and their clinical implications. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1451398

Vancouver

Lyu J, Huang J, Huang J, Hu H, Wang Q, Ding H, et al. Rising challenges in periprosthetic joint infections: a focus on rare pathogens and their clinical implications. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1451398

BibTeX
@article{Lyu2024,
  author = {Lyu, Jianhua and Huang, Jiagu and Huang, Jiexin and Hu, Hongxin and Wang, Qijin and Ding, Haiqi and Li, Hongyan and Fang, Xinyu and Zhang, Wenming},
  title = {Rising challenges in periprosthetic joint infections: a focus on rare pathogens and their clinical implications},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1451398}
}
Kostenlos starten →